Bbva Compass Bancshares Inc. Cuts Stake in Nu Skin Enterprises, Inc. (NYSE:NUS)

Bbva Compass Bancshares Inc. lowered its stake in Nu Skin Enterprises, Inc. (NYSE:NUS) by 6.2% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 4,770 shares of the company’s stock after selling 313 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Nu Skin Enterprises were worth $300,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in NUS. Great West Life Assurance Co. Can boosted its position in Nu Skin Enterprises by 3.2% in the second quarter. Great West Life Assurance Co. Can now owns 30,690 shares of the company’s stock valued at $1,928,000 after buying an additional 962 shares during the period. ING Groep NV purchased a new position in Nu Skin Enterprises during the second quarter valued at $380,000. Parametrica Management Ltd bought a new position in Nu Skin Enterprises during the second quarter worth $357,000. US Bancorp DE boosted its position in Nu Skin Enterprises by 3.3% in the second quarter. US Bancorp DE now owns 2,032 shares of the company’s stock worth $128,000 after buying an additional 65 shares during the last quarter. Finally, State Treasurer State of Michigan boosted its position in Nu Skin Enterprises by 2.0% in the second quarter. State Treasurer State of Michigan now owns 20,500 shares of the company’s stock worth $1,288,000 after buying an additional 400 shares during the last quarter. Institutional investors and hedge funds own 84.53% of the company’s stock.

Nu Skin Enterprises, Inc. (NYSE:NUS) traded up 3.16% during trading on Friday, reaching $55.48. 995,807 shares of the company’s stock were exchanged. Nu Skin Enterprises, Inc. has a 12-month low of $46.35 and a 12-month high of $66.04. The company has a market cap of $2.94 billion, a P/E ratio of 18.56 and a beta of 1.31. The stock’s 50-day moving average is $61.67 and its 200-day moving average is $56.55.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 EPS for the quarter, topping the consensus estimate of $0.69 by $0.08. The company had revenue of $550.10 million during the quarter, compared to analyst estimates of $548.09 million. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. Nu Skin Enterprises’s quarterly revenue was down 8.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.79 earnings per share. Analysts predict that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Friday, August 25th will be paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 2.60%. The ex-dividend date of this dividend is Wednesday, August 23rd. Nu Skin Enterprises’s payout ratio is 48.81%.

ILLEGAL ACTIVITY WARNING: This piece was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another publication, it was illegally copied and republished in violation of international copyright law. The legal version of this piece can be viewed at https://www.com-unik.info/2017/08/19/bbva-compass-bancshares-inc-lowers-stake-in-nu-skin-enterprises-inc-nysenus-updated.html.

NUS has been the topic of a number of research analyst reports. Stifel Nicolaus set a $50.00 target price on shares of Nu Skin Enterprises and gave the company a “sell” rating in a research note on Thursday, August 3rd. Sidoti cut shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 target price on the stock. in a research note on Wednesday, April 26th. Pivotal Research reissued a “buy” rating and issued a $80.00 price target (up previously from $65.00) on shares of Nu Skin Enterprises in a research report on Thursday, June 22nd. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Finally, Deutsche Bank AG boosted their price target on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a research report on Wednesday, June 21st. Two research analysts have rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $62.88.

In other news, General Counsel D Matthew Dorny sold 7,500 shares of the business’s stock in a transaction on Thursday, August 10th. The shares were sold at an average price of $60.88, for a total transaction of $456,600.00. Following the completion of the sale, the general counsel now directly owns 52,230 shares of the company’s stock, valued at $3,179,762.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Ryan S. Napierski sold 8,000 shares of the business’s stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $65.00, for a total transaction of $520,000.00. Following the sale, the president now directly owns 68,170 shares of the company’s stock, valued at $4,431,050. The disclosure for this sale can be found here. Insiders have sold 31,750 shares of company stock valued at $1,946,810 over the last ninety days. 5.20% of the stock is owned by insiders.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

What are top analysts saying about Nu Skin Enterprises Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Nu Skin Enterprises Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit